Follow
Sprint Bioscience AB
Nasdaq First North Sweden (Sweden)
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Sector:
HEALTH CARE
>
Drug Manufacturers - Specialty & Generic
Sector:
TECHNOLOGY
Exercise
Price
14.50 SEK
Exercise period(s)
14 Feb - 28 Feb 2020
View Details
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
SPRINT
SE0006343745
Nasdaq First North Sweden
Sweden (SE)
Details of share in Sprint Bioscience AB with ticker SPRINT
Status
Active
Order book id
Amount of instruments
12 342 560
Par value
0.1000
Market cap
Currency
SEK
Segment
First North Premier
First trading date
07 Nov 2014
Terms
Type
Price
Pre-money valuation
Time
IPO
15.00 SEK
75.6M SEK
06 Oct - 24 Oct 2014
IPO in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
06 Oct - 24 Oct 2014
Subscription price
Price per share
15.00 SEK
Target to raise
22 500 000 SEK
Types
Pre-money valuation
75 600 000 SEK
Subscription block size
Minimum subscription
400
Record date
Offer status
Closed
Listing status
Listed
First trading date
07 Nov 2014
Issue terms
Wide dissemination is a priority.
Type
Price
Pre-money valuation
Time
New issue
37.00 SEK
242M SEK
15 Mar - 15 Mar 2016
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
15 Mar - 15 Mar 2016
Subscription price
Price per share
37.00 SEK
Target to raise
19 200 000 SEK
Types
Share issue
Pre-money valuation
242 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to a limited circle of institutional and private investors, through bookbuilding.
Type
Price
Pre-money valuation
Time
New issue
21.50 SEK
151.9M SEK
11 Sep - 11 Sep 2017
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
11 Sep - 11 Sep 2017
Subscription price
Price per share
21.50 SEK
Target to raise
11 000 000 SEK
Types
Share issue
Pre-money valuation
151 900 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to a limited circle of institutional and private investors, including Roosgruppen AB.
Type
Price
Pre-money valuation
Time
New issue
15.00 SEK
114M SEK
15 Feb - 01 Mar 2018
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
15 Feb - 01 Mar 2018
Subscription price
15.00 SEK
Price per share
15.00 SEK
Target to raise
37 900 000 SEK
Types
Share issue
Pre-money valuation
114 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:3. Shareholders have preferential rights to subscribe for one (1) unit, consisting of one (1) share and two (2) warrants of series 2018/2019:1, for each three (3) existing shares held on the record date.
Type
Price
Pre-money valuation
Time
Exercise
17.17 SEK
-
28 Jan - 08 Feb 2019
Option exercise terms for SPRINT TO 2018/2019
Former ticker
SPRITN TO 1
Market
Nasdaq First North Sweden
Exercise period(s)
28 Jan - 08 Feb 2019
Exercise price
17.17 SEK
Status
Closed
Issue terms
Three (3) subscription options gives the holder the right to subscribe for 1 new share at a price that is 70 % of the volume weighted average market price during 14-25 January 2019. But no lower thatn 15 SEK and not higher than 29 SEK. Exercise period is 28 January - 8 February 2019.
Type
Price
Pre-money valuation
Time
New issue
14.00 SEK
03 Oct 2019
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription date
03 Oct 2019
Subscription price
1 400.00 SEK
Price per share
14.00 SEK
Target to raise
10 010 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
100
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed issue, to a consortium led by Gerhard Dal and Råsunda Förvaltning. The issue consists of a total of 7150 Units. Each Unit consists of 100 shares of SEK 14 and 34 warrants of series 1 and 34 warrants of series 2. The warrants are issued free of charge and can provide up to SEK 7.4 million (SEK 3.5 million from TO 1 and SEK 3.9 million from TO 2).
Type
Ticker
ISIN
Market
OPTION
SPRITN TO1
SE0013282050
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRITN TO1
Status
Active
Order book id
183922
Amount of instruments
830 540
Market cap
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 Feb 2020
Terms
Each warrant Series 1 entitles the holder to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
Exercise
14.50 SEK
-
14 Feb - 28 Feb 2020
Option exercise terms for SPRITN TO1
Market
Nasdaq First North Sweden
Exercise period(s)
14 Feb - 28 Feb 2020
Exercise price
14.50 SEK
Status
Active
 
Issue terms
Each warrant Series 1 entitles the holder to subscribe for one (1) share.
Result of offer
At full subscription the company will receive 15 567 780 SEK.
Type
Ticker
ISIN
Market
OPTION
SPRINT TO2
SE0013282068
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO2
Status
Active
Order book id
183923
Amount of instruments
830 540
Market cap
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 May 2020
Terms
Each warrant of Series 2 entitles the holder to subscribe for one (1) share at a price corresponding to 30% discount on the volume-weighted price during the period 27 April 2020 - 8 May 2020, however, a maximum of SEK 16.
Type
Price
Pre-money valuation
Time
Exercise
16.00 SEK
-
14 May - 28 May 2020
Option exercise terms for SPRINT TO2
Former ISIN
SPRINT TO 2
Market
Nasdaq First North Sweden
Exercise period(s)
14 May - 28 May 2020
Exercise price
16.00 SEK
Status
Upcoming
Issue terms
Each warrant of Series 2 entitles the holder to subscribe for one (1) share at a price corresponding to 30% discount on the volume-weighted price during the period 27 April 2020 - 8 May 2020, however, a maximum of SEK 16.
Type
Ticker
ISIN
Market
SHARE
SPRINT
SE0006343745
Nasdaq First North Sweden
Sweden (SE)
Details of share in Sprint Bioscience AB with ticker SPRINT
Status
Active
Order book id
Amount of instruments
12 342 560
Par value
0.1000
Market cap
Currency
SEK
Segment
First North Premier
First trading date
07 Nov 2014
Terms
Type
Price
Pre-money valuation
Time
IPO
15.00 SEK
75.6M SEK
06 Oct - 24 Oct 2014
IPO in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
06 Oct - 24 Oct 2014
Subscription price
Price per share
15.00 SEK
Target to raise
22 500 000 SEK
Types
Pre-money valuation
75 600 000 SEK
Subscription block size
Minimum subscription
400
Record date
Offer status
Closed
Listing status
Listed
First trading date
07 Nov 2014
Issue terms
Wide dissemination is a priority.
Type
Price
Pre-money valuation
Time
New issue
37.00 SEK
242M SEK
15 Mar - 15 Mar 2016
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
15 Mar - 15 Mar 2016
Subscription price
Price per share
37.00 SEK
Target to raise
19 200 000 SEK
Types
Share issue
Pre-money valuation
242 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to a limited circle of institutional and private investors, through bookbuilding.
Type
Price
Pre-money valuation
Time
New issue
21.50 SEK
151.9M SEK
11 Sep - 11 Sep 2017
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
11 Sep - 11 Sep 2017
Subscription price
Price per share
21.50 SEK
Target to raise
11 000 000 SEK
Types
Share issue
Pre-money valuation
151 900 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to a limited circle of institutional and private investors, including Roosgruppen AB.
Type
Price
Pre-money valuation
Time
New issue
15.00 SEK
114M SEK
15 Feb - 01 Mar 2018
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
15 Feb - 01 Mar 2018
Subscription price
15.00 SEK
Price per share
15.00 SEK
Target to raise
37 900 000 SEK
Types
Share issue
Pre-money valuation
114 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:3. Shareholders have preferential rights to subscribe for one (1) unit, consisting of one (1) share and two (2) warrants of series 2018/2019:1, for each three (3) existing shares held on the record date.
Type
Price
Pre-money valuation
Time
New issue
14.00 SEK
03 Oct 2019
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription date
03 Oct 2019
Subscription price
1 400.00 SEK
Price per share
14.00 SEK
Target to raise
10 010 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
100
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed issue, to a consortium led by Gerhard Dal and Råsunda Förvaltning. The issue consists of a total of 7150 Units. Each Unit consists of 100 shares of SEK 14 and 34 warrants of series 1 and 34 warrants of series 2. The warrants are issued free of charge and can provide up to SEK 7.4 million (SEK 3.5 million from TO 1 and SEK 3.9 million from TO 2).
Type
Ticker
ISIN
Market
OPTION
SPRINT TO 2018/2019
SE0010833178
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO 2018/2019
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
Segment
First North Premier
First trading date
Terms
Three (3) subscription options gives the holder the right to subscribe for 1 new share at a price that is 70 % of the volume weighted average market price during 14-25 January 2019. But no lower thatn 15 SEK and not higher than 29 SEK. Exercise period is 28 January - 8 February 2019.
Type
Price
Pre-money valuation
Time
Exercise
17.17 SEK
-
28 Jan - 08 Feb 2019
Option exercise terms for SPRINT TO 2018/2019
Former ticker
SPRITN TO 1
Market
Nasdaq First North Sweden
Exercise period(s)
28 Jan - 08 Feb 2019
Exercise price
17.17 SEK
Status
Closed
Issue terms
Three (3) subscription options gives the holder the right to subscribe for 1 new share at a price that is 70 % of the volume weighted average market price during 14-25 January 2019. But no lower thatn 15 SEK and not higher than 29 SEK. Exercise period is 28 January - 8 February 2019.
Type
Ticker
ISIN
Market
OPTION
SPRITN TO1
SE0013282050
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRITN TO1
Status
Active
Order book id
183922
Amount of instruments
830 540
Market cap
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 Feb 2020
Terms
Each warrant Series 1 entitles the holder to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
Exercise
14.50 SEK
-
14 Feb - 28 Feb 2020
Option exercise terms for SPRITN TO1
Market
Nasdaq First North Sweden
Exercise period(s)
14 Feb - 28 Feb 2020
Exercise price
14.50 SEK
Status
Active
 
Issue terms
Each warrant Series 1 entitles the holder to subscribe for one (1) share.
Result of offer
At full subscription the company will receive 15 567 780 SEK.
Type
Ticker
ISIN
Market
OPTION
SPRINT TO2
SE0013282068
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO2
Status
Active
Order book id
183923
Amount of instruments
830 540
Market cap
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 May 2020
Terms
Each warrant of Series 2 entitles the holder to subscribe for one (1) share at a price corresponding to 30% discount on the volume-weighted price during the period 27 April 2020 - 8 May 2020, however, a maximum of SEK 16.
Type
Price
Pre-money valuation
Time
Exercise
16.00 SEK
-
14 May - 28 May 2020
Option exercise terms for SPRINT TO2
Former ISIN
SPRINT TO 2
Market
Nasdaq First North Sweden
Exercise period(s)
14 May - 28 May 2020
Exercise price
16.00 SEK
Status
Upcoming
Issue terms
Each warrant of Series 2 entitles the holder to subscribe for one (1) share at a price corresponding to 30% discount on the volume-weighted price during the period 27 April 2020 - 8 May 2020, however, a maximum of SEK 16.
People
Number of Employees
30 people
Anders Åberg
CEO
Rune Nordlander
Chairman of the board
Rune Nordlander
Board member
Karin Meyer
Board member
Charlotta Liljebris
Board member
Ingemar Kihlström
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY

Address
C/O Novum
Zip code
141 57
City/district
Huddinge
Country
Sweden (SE)
Registration number
556789-7557
LEI code
5493006ED74WIIQOKC56
First trade date
07 Nov 2014
Registration date
28 Sep 2009
Short name
Sprint Bioscience

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date